Quantification of O-(2-[18F]fluoroethyl)-L-tyrosine kinetics in glioma

被引:13
|
作者
Koopman, Thomas [1 ]
Verburg, Niels [2 ,3 ]
Schuit, Robert C. [1 ]
Pouwels, Petra J. W. [1 ]
Wesseling, Pieter [4 ,5 ,6 ]
Windhorst, Albert D. [1 ]
Hoekstra, Otto S. [1 ]
Hamer, Philip C. de Witt [2 ,3 ]
Lammertsma, Adriaan A. [1 ]
Boellaard, Ronald [1 ,7 ]
Yaqub, Maqsood [1 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, Dept Radiol & Nucl Med, POB 7057, NL-1007 MB Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Neurosurg Ctr Amsterdam, Amsterdam, Netherlands
[3] Brain Tumor Ctr Amsterdam, Amsterdam, Netherlands
[4] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands
[5] Princess Maxima Ctr Pediat Oncol, Dept Pathol, Utrecht, Netherlands
[6] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands
[7] Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands
来源
EJNMMI RESEARCH | 2018年 / 8卷
关键词
FET; Quantification; Kinetic modelling; SUV; SUVR; POSITRON-EMISSION-TOMOGRAPHY; REFERENCE TISSUE MODEL; PET; BRAIN; BINDING; TRANSPORT; F-18-FET; TUMORS;
D O I
10.1186/s13550-018-0418-0
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: This study identified the optimal tracer kinetic model for quantification of dynamic O-(2-[F-18] fluoroethyl)-L-tyrosine ([F-18]FET) positron emission tomography (PET) studies in seven patients with diffuse glioma (four glioblastoma, three lower grade glioma). The performance of more simplified approaches was evaluated by comparison with the optimal compartment model. Additionally, the relationship with cerebral blood flow-determined by [O-15]H2O PET-was investigated. Results: The optimal tracer kinetic model was the reversible two-tissue compartment model. Agreement analysis of binding potential estimates derived from reference tissue input models with the distribution volume ratio (DVR)-1 derived from the plasma input model showed no significant average difference and limits of agreement of -0.39 and 0.37. Given the range of DVR-1 (-0.25 to 1.5), these limits are wide. For the simplified methods, the 60-90 min tumour-to-blood ratio to parent plasma concentration yielded the highest correlation with volume of distribution V-T as calculated by the plasma input model (r = 0.97). The 60-90 min standardized uptake value (SUV) showed better correlation with V-T (r = 0.77) than SUV based on earlier intervals. The 60-90 min SUV ratio to contralateral healthy brain tissue showed moderate agreement with DVR with no significant average difference and limits of agreement of -0.24 and 0.30. A significant but low correlation was found between V-T and CBF in the tumour regions (r = 0.61, p = 0.007). Conclusion: Uptake of [F-18] FET was best modelled by a reversible two-tissue compartment model. Reference tissue input models yielded estimates of binding potential which did not correspond well with plasma input-derived DVR-1. In comparison, SUV ratio to contralateral healthy brain tissue showed slightly better performance, if measured at the 60-90 min interval. SUV showed only moderate correlation with V-T. V-T shows correlation with CBF in tumour.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Synthesis of O-(2-[18F]Fluoroethyl)-L-tyrosine based on a cartridge cleaning method
    Mueller, Dirk
    Klette, Ingo
    Kalb, Fabrizia
    Baum, Richard
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [22] Influence of Dexamethasone on O-(2-[18F]-Fluoroethyl)-l-Tyrosine Uptake in the Human Brain and Quantification of Tumor Uptake
    Carina Stegmayr
    Gabriele Stoffels
    Elena Rota Kops
    Philipp Lohmann
    Norbert Galldiks
    Nadim J. Shah
    Bernd Neumaier
    Karl-Josef Langen
    [J]. Molecular Imaging and Biology, 2019, 21 : 168 - 174
  • [23] Influence of Dexamethasone on O-(2-[18F]-Fluoroethyl)-l-Tyrosine Uptake in the Human Brain and Quantification of Tumor Uptake
    Stegmayr, Carina
    Stoffels, Gabriele
    Kops, Elena Rota
    Lohmann, Philipp
    Galldiks, Norbert
    Shah, Nadim J.
    Neumaier, Bernd
    Langen, Karl-Josef
    [J]. MOLECULAR IMAGING AND BIOLOGY, 2019, 21 (01) : 168 - 174
  • [24] Use of 2-[18F]fluoroethyl bromide in synthesis of O-(2'-[ 18F]fluoroethyl)-L-tyrosine, a radiotracer for PET diagnostics of brain tumors
    Gomzina N.A.
    Vasil'ev D.A.
    Krasikova R.N.
    [J]. Radiochemistry, 2007, 49 (3) : 299 - 304
  • [25] Microfluidic technology: An economical and versatile approach for the synthesis of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET)
    Bouvet, Vincent
    Wuest, Melinda
    Tam, Pui-Hang
    Wang, Monica
    Wuest, Frank
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (06) : 2291 - 2295
  • [26] Development of an economical method to synthesize O-(2-[18F]fluoroethyl)-L-tyrosine (18FFET)
    Kumar, Aishwarya
    Joshi, Raman Kumar
    Thakur, Riptee
    Kumar, Dinesh
    Nagaraj, Chandana
    Kumar, Pardeep
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2023, 66 (11): : 345 - 352
  • [27] Serial O-(2-[18F] fluoroethyl)-L-tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant glioma
    Poepperl, Gabriele
    Goetz, Claudia
    Rachinger, Walter
    Schnell, Oliver
    Gildehaus, Franz J.
    Tonn, Joerg C.
    Tatsch, Klaus
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (07) : 792 - 800
  • [28] PREDICTION OF OVERALL SURVIVAL IN PATIENTS WITH MALIGNANT GLIOMA USING DYNAMIC O-(2-[18F]-FLUOROETHYL)-L-TYROSINE PET
    Bauer, E. K.
    Stoffels, G.
    Blau, T.
    Reifenberger, G.
    Werner, J. M.
    Lohmann, P.
    Rapp, M.
    Fink, G. R.
    Langen, K.
    Galldiks, N.
    [J]. NEURO-ONCOLOGY, 2019, 21 : 73 - 73
  • [29] Microfluidic technology: An economical and versatile approach for the synthesis of O-(2-[18F]fluoroethyl)-L-tyrosine [18F]FET
    Bouvet, Vincent R.
    Tam, Pui-Hang
    Wuest, Melinda
    Wang, Monica
    Wuest, Frank
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2011, 54 : S545 - S545
  • [30] Serial O-(2-[18F]fluoroethyl)-L-tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant glioma
    Gabriele Pöpperl
    Claudia Götz
    Walter Rachinger
    Oliver Schnell
    Franz J. Gildehaus
    Joerg C. Tonn
    Klaus Tatsch
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2006, 33 : 792 - 800